HomeNECLIFE • NSE
add
Nectar Lifesciences Ltd
Previous close
₹32.50
Day range
₹31.87 - ₹33.00
Year range
₹26.15 - ₹56.50
Market cap
7.50B INR
Avg Volume
687.77K
P/E ratio
69.24
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.28B | 7.52% |
Operating expense | 1.04B | 5.51% |
Net income | 55.99M | 451.45% |
Net profit margin | 1.31 | 403.85% |
Earnings per share | — | — |
EBITDA | 432.89M | 61.08% |
Effective tax rate | 35.39% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 187.35M | -7.94% |
Total assets | 21.83B | 1.89% |
Total liabilities | 11.05B | 2.80% |
Total equity | 10.78B | — |
Shares outstanding | 223.96M | — |
Price to book | 0.68 | — |
Return on assets | — | — |
Return on capital | 4.07% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 55.99M | 451.45% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic drug products. The company has global leadership in several oral and sterile cephalosporin drugs, and has cGMP facilities along with those approved by the European Union and Japan. Wikipedia
Founded
1995
Headquarters
Website
Employees
1,686
